Company: GEHC
Filing Date: 2025-02-13
Form Type: 10-K
Source: 0001932393-25-000005
Chunk: 186

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-02-13
Form: 10-K
Item: Item 7
Chunk 186
---
3(15)(34)Add: Spin-Off and separation costs(3)    25127014Add: (Gain) loss on business and asset dispositions(4)    ——(1)Add: Amortization of acquisition-related intangible assets    137127121Add: Investment revaluation (gain) loss(5)    22(1)31Adjusted EBIT*    $3,211$2,956$2,8619%3%Net income margin10.1%8.0%10.4%210 bps(240) bpsAdjusted EBIT margin*    16.3%15.1%15.6%120 bps(50) bps

(1)Consists of severance, facility closures, and other charges associated with restructuring programs.(2)Consists of legal, consulting, and other transaction and integration fees, and adjustments to contingent consideration, as well as other purchase accounting related charges and other costs directly related to the transactions.(3)Costs incurred in the Spin-Off and separation from GE, including system implementations, audit and advisory fees, legal entity separation, Founders Grant equity awards, separation agreements with GE, and other one-time costs.(4)Consists of gains and losses resulting from the sale of assets and investments.(5)Primarily relates to valuation adjustments for equity investments.

Adjusted Net Income*For the years ended December 312024202320222024 vs. 2023 % change2023 vs. 2022 % changeNet income attributable to GE HealthCare    $1,993$1,568$1,91627%(18)%Add: Non-operating benefit (income) costs    (406)(382)(5)Add: Restructuring costs(1)    12054146Add: Acquisition and disposition-related charges (benefits)(2)    3(15)(34)Add: Spin-Off and separation costs(3)    25127014Add: (Gain) loss on business and asset dispositions(4)    ——(1)Add: Amortization of acquisition-related intangible assets    137127121Add: Investment revaluation (gain) loss(5)    22(1)31Add: Tax effect of reconciling items(6)(42)(24)(67)Add: Spin-Off and other tax adjustments(7)    (17)196—Less: Income (loss) from